PRICE T ROWE ASSOCIATES INC /MD/ - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 212 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$1,683
-83.8%
308,751
-80.0%
0.00%
-100.0%
Q2 2023$10,383
-33.2%
1,547,292
-12.0%
0.00%
-50.0%
Q1 2023$15,533
+10.6%
1,758,949
-4.3%
0.00%0.0%
Q4 2022$14,045
-99.9%
1,838,466
-2.8%
0.00%0.0%
Q3 2022$13,472,000
-86.3%
1,892,084
-84.5%
0.00%
-83.3%
Q2 2022$98,568,000
-42.8%
12,183,895
-1.9%
0.01%
-29.4%
Q1 2022$172,339,000
-53.8%
12,416,367
-6.6%
0.02%
-50.0%
Q4 2021$372,825,000
-4.2%
13,286,713
+16.1%
0.03%
-8.1%
Q3 2021$389,057,000
-13.2%
11,446,222
+4.4%
0.04%
-11.9%
Q2 2021$448,107,000
+15.6%
10,966,891
+14.0%
0.04%
+7.7%
Q1 2021$387,471,000
+10.0%
9,624,225
+61.6%
0.04%
+8.3%
Q4 2020$352,106,000
+88.5%
5,954,776
+55.1%
0.04%
+63.6%
Q3 2020$186,759,000
+41.7%
3,840,398
+41.0%
0.02%
+29.4%
Q2 2020$131,757,000
+43.6%
2,723,373
-17.6%
0.02%
+13.3%
Q1 2020$91,772,000
+39.3%
3,303,520
+50.0%
0.02%
+66.7%
Q4 2019$65,884,000
+201.6%
2,201,998
+211.5%
0.01%
+200.0%
Q3 2019$21,844,000
-49.7%
706,924
-21.5%
0.00%
-50.0%
Q2 2019$43,470,000900,0000.01%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q4 2021
NameSharesValueWeighting ↓
Eagle Health Investments LP 1,014,860$14,086,0003.47%
Triatomic Management LP 297,048$4,123,0003.35%
Diametric Capital, LP 265,000$3,678,0002.03%
Matrix Capital Management Company, LP 11,572,590$160,628,0001.93%
VIKING GLOBAL INVESTORS LP 29,993,708$416,313,0001.68%
TIGER MANAGEMENT L.L.C. 589,311$8,180,0001.35%
Aristotle Atlantic Partners, LLC 759,412$10,541,0000.65%
Casdin Capital, LLC 1,000,000$13,880,0000.62%
Pier Capital, LLC 339,541$4,713,0000.60%
Leeward Financial Partners, LLC 68,504$951,0000.59%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders